Study title:
Horowitz-M-E, Mulhern-R-K, Kun-L-E, Kovnar-E, Sanford-R-A, Simmons-J, Hayes-F-A, Jenkins-III-J-J.
Department of Hematology-Oncology, St. Jude Children's Research
Hospital, Memphis, TN, United States.
Brain tumors in the very young child. Postoperative chemotherapy in combined-modality treatment.
Cancer {CANCER}, 1988, Vol/Iss/Pg. 61/3 (428-434), ISSN: 0008-543X.Horowitz-M-E, Mulhern-R-K, Kun-L-E, Kovnar-E, Sanford-R-A, Simmons-J, Hayes-F-A, Jenkins-III-J-J.
Department of Hematology-Oncology, St. Jude Children's Research
Hospital, Memphis, TN, United States.
Brain tumors in the very young child. Postoperative chemotherapy in combined-modality treatment.
Cancer {CANCER}, 1988, Vol/Iss/Pg. 61/3 (428-434), ISSN: 0008-543X.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|